APRA is an interdisciplinary, academic association for researchers and university students based in Amsterdam, focusing on substances and practices that show promise for therapy and scientific value, but that suffer an impaired research development because of their legal status or psychoactive effects. Most notably, this definition includes classical psychedelics (e.g. LSD, psilocybin), cannabis and MDMA.
- The recognition of the research and therapeutic value of psychedelic substances, for which scientific evidence is now abundant [1,2,3,4,…]
- The persistence of anecdotal beliefs and stigma regarding psychedelics, particularly within academia
- The current absence of dedicated research efforts within this field in Amsterdam-area institutions.
Therefore, the Amsterdam Psychedelic Research Association was formed to fill in this niche.
In practice, we aim to:
- Provide information to students and researchers about developments in academic research on psychedelics through lectures, journal clubs, seminars.
- Diminish unscientific stigma within academia and help normalize the status of education and research in this field.
- Promote the start of a concerted, interdisciplinary research effort in this direction within the Amsterdam institutions.
APRA does not encourage illegal drug use outside controlled research and medical contexts, and promotes all available harm-reduction strategies.
University students, researchers or faculty based at Amsterdam institutions, that are interested in actively collaborating are particularly encouraged to become members and contact us at:
We encourage students and researchers from other cities and countries to start similar initiatives, and get in touch with us, to move together towards a collaborative network of psychedelic research associations.
More detailed information can be found here.